Amy Legg
@leggwamy.bsky.social
📤 36
📥 39
📝 11
Pharmacist, footy, vancomycin.
reposted by
Amy Legg
Jason Trubiano
11 days ago
The largest adult
#penicillinallergy
study ever undertaken - The iNAAN study
@thedohertyinst.bsky.social
@unimelb.bsky.social
- 52 hospitals, 8 countries and over 5000 patients….Real world proof of the safety and effectiveness of inpatient DOC! Stay tuned
#AMS
folks 👀Results soon!
0
9
3
reposted by
Amy Legg
Jason Trubiano
11 days ago
Is one dose ever enough? The PROSPECTOR 🪓 Trial will answer - A international double blind placebo controlled trial of 1 dose vs 5 day for
#penicillinallergy
. This week we recruited our 100th patient! 🎉
@thedohertyinst.bsky.social
0
5
3
reposted by
Amy Legg
CRE Respond
2 months ago
👏CRE RESPOND is thrilled to announce the Sepsis: What is the Latest Data for Optimal Management of Sepsis seminar!👏 🗓️When: Thursday 16 October, 12pm-1pm (AEST) 🗺️Where: UQCCR (or online!) REGISTER HERE:
bit.ly/3VBLeSx
Don't miss out on the chance to hear from expert clinicians and researchers!
0
1
2
reposted by
Amy Legg
CRE Respond
2 months ago
The whole team at CRE RESPOND are very proud of our very own Amy Legg on her graduation! Congratulations Amy!! 👏🎉
@leggwamy.bsky.social
add a skeleton here at some point
1
1
1
Graduation nation! Huge thanks to the supers
@gurujosh.bsky.social
@steventong.bsky.social
Jane Davies, Jason Roberts. Look after your kidneys guys!
3 months ago
4
4
1
reposted by
Amy Legg
CRE Respond
3 months ago
🤩Dr Andrew Burke's recent presentation on 'Therapeutic Drug Monitoring in Non-Tuberculous Mycobacteria' was not one to miss... 📢Luckily, even if you weren't able to attend the Respiratory Infections seminar, you won't have to!
youtu.be/V2nITG_rxp8?...
loading . . .
03 Dr Andrew Burke - Therapeutic Drug Monitoring in Non-Tuberculous Mycobacteria
YouTube video by cre.respond
https://youtu.be/V2nITG_rxp8?si=j3WrIID8EQD4N1KH
0
1
1
reposted by
Amy Legg
Jason Trubiano
3 months ago
Congratulations Elise Mitri from NACE, Austin Health & The Peter Doherty Institute presenting the iNAAN Trial results - > 5000 pts & 1500 inpatient
#penicillinallergy
DOC performed. Safe irrespective of stakeholder with significant prescribing gains. Largest inpatient penicillin allergy study 👏🎉
0
4
1
reposted by
Amy Legg
CRE Respond
5 months ago
On 7 August 2025, we will be hosting our Worldwide Precision Dosing seminar for the fifth year!💉 📢Chaired by Dr Amy Legg, a clinical pharmacist at RBWH, this event explores individualised drug therapy. To find out more about this event and register:
bit.ly/3GtrIUb
@leggwamy.bsky.social
#UQCCR
0
1
1
Always happy to celebrate you
@minyonavent.bsky.social
❤️ what a packet of legends
add a skeleton here at some point
6 months ago
0
1
0
reposted by
Amy Legg
CRE Respond
6 months ago
✨Hello and welcome to the official CRE Respond page!✨ CRE RESPOND aims to reduce the burden of antimicrobial resistance through optimal personalised dosing. 💊 🚨Follow us to stay up to date with our educational events and the latest goings-on in the world of anti-microbial optimisation!
#uqccr
0
3
1
reposted by
Amy Legg
Angela Huttner
8 months ago
Congrats to
@elisemitri.bsky.social
,
@trubianojason.bsky.social
et al for their great work on safely delabeling patients with
#penicillinallergy
. Elise presenting their prospective, pharmacist-led program live at
#ESCMIDGlobal
#IDSky
#PharmSky
#openacess
www.cmi-comms.com/article/S295...
0
43
5
reposted by
Amy Legg
Josh Davis
10 months ago
#SNAPtrial
will answer this question in a large RCT (rather than observational). Come to ESCMID global and hear the results!
0
23
6
reposted by
Amy Legg
Josh Davis
10 months ago
Approaching more than all previous SAB trials combined! What next?!
add a skeleton here at some point
0
12
3
Interested in PK modelling? CRE RESPOND is running its Population Pharmacokinetics workshop, from fundamentals to clinical practice. Much more practical program this year! Be quick spaces are limited. Register here:
bit.ly/3ElRmJ6
loading . . .
Population pharmacokinetics: from fundamentals to clinical practice
Are you looking to enhance your knowledge of pharmacokinetics (PK) and gain hands-on experience with population pharmacokinetic (popPK) modelling? Whether you are new to the field or looking to deepen...
https://bit.ly/3ElRmJ6
10 months ago
0
0
0
Really excited by this article from
@idpharmacometrx.bsky.social
et al. Protamine as the prototype for megalin blockade to reduce/delay kidney accumulation of vanc (and maybe colistin and aminoglycosides…). But also an excellent VIKI overview, fab pics 💕
journals.asm.org/doi/10.1128/...
loading . . .
Protamine protects against vancomycin-induced kidney injury | Antimicrobial Agents and Chemotherapy
Vancomycin is one of the most widely used antibiotics within United States in-patient healthcare systems, accounting for 11.9% of all antibiotic use for inpatient antimicrobials (1,258 out of 10,612) ...
https://journals.asm.org/doi/10.1128/aac.01236-24
10 months ago
1
6
2
I learnt to name studies from the best!
add a skeleton here at some point
11 months ago
0
0
0
reposted by
Amy Legg
Antibiotic Steward 🅱️C🆔🅿️🌟
11 months ago
🆕💫Retrospective cohort study
#CMI
AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia
#idsky
#EMIMCC
www.clinicalmicrobiologyandinfection.com/article/S119...
loading . . .
DEFINE_ME
https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(24)00641-4/abstract
0
8
6
reposted by
Amy Legg
Antibiotic Steward 🅱️C🆔🅿️🌟
11 months ago
**Starting 2025 with a key update: The new ATS/CDC/ERS/IDSA guidelines on treating drug-susceptible and drug-resistant tuberculosis (TB) are out! What do you think about these changes? How will they shape clinical practice moving forward?**
#idsky
#tbsky
#EMIMCC
add a skeleton here at some point
1
12
6
reposted by
Amy Legg
Antibiotic Steward 🅱️C🆔🅿️🌟
12 months ago
Pharmacodynamic studies indicate that anaerobic killing is optimized when the plasma AUC) to MIC ratio is ≥70:1; the probability of achieving this target with 1000mg/d of metronidazole is > 99% against B. fragilis that exhibit MICs < 2mg/L
#idsky
#medsky
#EMIMCC
add a skeleton here at some point
2
11
5
reposted by
Amy Legg
Antibiotic Steward 🅱️C🆔🅿️🌟
12 months ago
🆕🔥Retrospective, multicenter, inverse probability-of-treatment weighted cohort study Among hospitalized patients with septic shock, there was no difference between cefepime and piperacillin-tazobactam on the occurrence of severe AKI
#idsky
#medsky
academic.oup.com/cid/advance-...
1
4
2
Just in case you missed it Dr Emily Heil and Dr Julie Ann Justo with the greatest overview of aminoglycoside dosing for
#UQCCR
earlier this year! All the recordings here
cre-respond.centre.uq.edu.au/event/sessio...
loading . . .
Worldwide Precision Dosing Seminar
CRE RESPOND's fourth Annual Worldwide Precision Dosing seminar was held on Tuesday 10 September. Our panel of expert clinicians and clinical educators, from America, Europe and Australia, covered whe...
https://cre-respond.centre.uq.edu.au/event/session/2284
12 months ago
0
2
0
you reached the end!!
feeds!
log in